MPG.eBooks - Search Results - "Hypertension / Drug Therapy"

Cover Image

1

Hypertension : management in adults in primary care : pharmacological update

Published 2006

Royal College of Physicians

Subjects: “...Hypertension / drug therapy...”

Cover Image

2

Evidence for the reaffirmation of the U.S. Preventive Services Task force recommendation on screening for high blood pressure

by Wolff, Tracy, Miller, Therese
Published 2007

Agency for Healthcare Research and Quality (US)

Subjects: “...Hypertension / drug therapy...”

Cover Image

3

Future research needs for angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), or direct renin inhibitors (DRIs) for treating hypertension...

by Powers, Benjamin J.
Published 2012

Agency for Healthcare Research and Quality

Subjects: “...Hypertension / drug therapy...”

Cover Image

4

Future research needs for angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), or direct renin inhibitors (DRIs) for treating hypertension...

by Powers, Benjamin J.
Published 2012

Agency for Healthcare Research and Quality

Subjects: “...Hypertension / drug therapy...”

Cover Image

5

CADTH Canadian Drug Expert Committee recommendation: Latanoprostene bunod (Vyzulta -- Bausch Health, Canada Inc.) : indication : for the reduction of intraocular pressure (IOP) in...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

6

Clinical review report: Latanoprostene bunod (Vyzulta) : (Bausch Health Canada Inc.)

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

7

Clinical review report: Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on behalf of Icon Canada Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

8

Prostaglandin analogues for ophthalmic use : a review of the comparative clinical effectiveness and cost-effectiveness

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

9

Angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), and direct renin inhibitors for treating essential hypertension : an update

by Sanders, Gillian D.
Published 2011

Agency for Healthcare Research and Quality

Subjects: “...Hypertension / drug therapy...”

Cover Image

10

Pharmacoeconomic review report: Latanoprostene bunod (Vyzulta) : (Bausch Health Canada Inc.)

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

11

Prostaglandin analogues for ophthalmic use : a review of comparative clinical effectiveness, cost-effectiveness, and guidelines

by Islam, Saadul, Spry, Carolyn
Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

12

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

13

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

14

Clinical review report: Preservative-free latanoprost 50 [m]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

15

Clinical review report: Preservative-free latanoprost 50 [m]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Cover Image

16

Angiotensin-converting enzyme (ACE) inhibitors : a review of the comparative clinical and cost-effectiveness

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Hypertension / drug therapy...”

Cover Image

17

Comparative effectiveness of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs) for treating essential hypertension

by Matchar, David B.
Published 2007

Agency for Healthcare Research and Quality, Department of Health and Human Services, USA

Subjects: “...Hypertension / drug therapy...”

Cover Image

18

Comparative effectiveness of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor antagonists (ARBs) for treating essential hypertension

by Matchar, David B.
Published 2007

Agency for Healthcare Research and Quality, Department of Health and Human Services, USA

Subjects: “...Hypertension / drug therapy...”